Oura to Buy AI Care Company Counsel Health for $625 Million

Nov 10, 2026
Oura agreed to buy AI-native primary care company Counsel Health for $625 million in cash, as its quarterly revenue grew 153% to $533 million.

Oura agreed to buy Counsel Health, an AI-native primary care company, for $625 million in cash, the companies announced. The deal is expected to close before the end of the calendar year.

Counsel pairs medical AI with in-house physicians. Oura members can start from an Oura insight or a chat with Counsel's AI, which draws on medical records, clinical guidelines and biometric data, and can bring in a Counsel physician who can diagnose, prescribe and refer. Counsel will keep serving health plans, health systems and employers.

Counsel CEO Muthu Alagappan will become Oura's chief clinical AI officer, and Counsel's 70 employees will join him, Quartz reported, citing Bloomberg.

Oura announced the deal with preliminary results for its fiscal fourth quarter, ended 30 September. Revenue grew 153% to $533 million, with $87 million in adjusted EBITDA. Fiscal 2026 revenue was about $1.75 billion, up 92%. Oura has more than six million members.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.